Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 24.99% | 50.03% | 39.21% | 44.71% | 0.31% |
| Total Depreciation and Amortization | -34.57% | -10.58% | -3.06% | -31.37% | -29.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.16% | -2,125.00% | -3,005.45% | -377.98% | 36.35% |
| Change in Net Operating Assets | -32.12% | -32.66% | -32.72% | -179.21% | 242.96% |
| Cash from Operations | 20.93% | 49.32% | 33.18% | -76.23% | 24.87% |
| Capital Expenditure | -- | -51.18% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -168.64% | -100.00% | -100.00% | -32.57% | 41.95% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -168.64% | -95.64% | -100.00% | -32.57% | 41.95% |
| Total Debt Issued | -37.08% | -28.54% | -17.73% | 102.02% | -10.99% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -74.21% | -62.48% |
| Cash from Financing | -42.61% | -42.89% | -39.63% | 51.74% | -20.58% |
| Foreign Exchange rate Adjustments | 165.30% | 50.45% | 124.25% | 119.16% | -30.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.22% | 101.06% | 42.86% | 3.57% | -130.26% |